CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,622 | +117.5% | 377 | +59.7% | 0.00% | – |
Q2 2023 | $2,585 | +25.6% | 236 | 0.0% | 0.00% | – |
Q1 2023 | $2,058 | +39.1% | 236 | 0.0% | 0.00% | – |
Q4 2022 | $1,480 | +48.0% | 236 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 236 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 236 | -45.7% | 0.00% | – |
Q1 2022 | $1,000 | – | 435 | +306.5% | 0.00% | – |
Q2 2021 | $0 | – | 107 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |